Here are six points:
1. Aurora Spine’s Q3 revenues hit nearly $1.63 million, reflecting a 39 percent increase from the same period in 2015.
2. The company’s 2016 Q3 net loss decreased from $615,122 in Q3 of 2015 to $523,007.
3. Aurora Spine’s ZIP products revenue increased by 93 percent in Q3 of 2016, up from the same period the year prior.
4. The company’s TiNano Interbody cages revenue increased by more than 26 percent in Q3 of 2016, compared to Q3 of 2015.
5. Hardware revenue in Q3 of 2016 grew by 45 percent, compared to the hardware revenue in Q3 of 2015.
6. The company boosted its surgeon base by about 25 percent in the third quarter of 2016, over the surgeon base in 2015.
More articles on devices:
StemGenex offers recommendations for the FDA’s regulation of stem cell therapy: 5 insights
Global lumbar spine fusion market to grow at CAGR of 4.9% to 2020: 4 highlights
1st AxioMed viscoelastic Freedom cervical case performed in Australia: 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
